Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies

B Pardini, AA Sabo, G Birolo, GA Calin - Cancers, 2019‏ - mdpi.com
The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies

E Larrea, C Sole, L Manterola, I Goicoechea… - International journal of …, 2016‏ - mdpi.com
The effective and efficient management of cancer patients relies upon early diagnosis and/or
the monitoring of treatment, something that is often difficult to achieve using standard tissue …

Plasma processing conditions substantially influence circulating microRNA biomarker levels

HH Cheng, HS Yi, Y Kim, EM Kroh, JW Chien… - PloS one, 2013‏ - journals.plos.org
Circulating, cell-free microRNAs (miRNAs) are promising candidate biomarkers, but optimal
conditions for processing blood specimens for miRNA measurement remain to be …

U6 is not a suitable endogenous control for the quantification of circulating microRNAs

M **ang, Y Zeng, R Yang, H Xu, Z Chen… - Biochemical and …, 2014‏ - Elsevier
Recently, microRNAs have been detected in serum and plasma, and circulating microRNA
(miRNA) profiles have now been associated with many diseases such as cancers and heart …

Serum, plasma and saliva biomarkers for head and neck cancer

LMRB Arantes, AC De Carvalho… - Expert review of …, 2018‏ - Taylor & Francis
Introduction: Head and neck squamous cell carcinoma (HNSCC) encompasses tumors
arising from several locations (oral and nasal cavities, paranasal sinuses, salivary glands …

Diverse roles of miR-29 in cancer

H Jiang, G Zhang, JH Wu, CP Jiang - Oncology reports, 2014‏ - spandidos-publications.com
Abstract microRNAs (miRNAs) are non-coding RNAs which have the capacity to regulate
gene expression at the post-transcriptional level, and have emerging as key factors involved …

circMAN1A2 could serve as a novel serum biomarker for malignant tumors

CM Fan, JP Wang, YY Tang, J Zhao, SY He… - Cancer …, 2019‏ - Wiley Online Library
Novel diagnostic and prognostic biomarkers of cancers are needed to improve precision
medicine. Circular RNA s act as important regulators in cancers at the transcriptional and …

Circulating microRNA signature for the diagnosis of very high-risk prostate cancer

AH Alhasan, AW Scott, JJ Wu, G Feng… - Proceedings of the …, 2016‏ - National Acad Sciences
We report the identification of a molecular signature using the Scano-miR profiling platform
based on the differential expression of circulating microRNAs (miRNA, miR) in serum …

MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis

Z Jamali, NA Aminabadi, R Attaran, F Pournagiazar… - Oral oncology, 2015‏ - Elsevier
The aim of this study was to systematically review the articles investigating the prognostic
value of different microRNAs (miRs) in human head and neck squamous cell carcinoma …

MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition

L Wang, XJ Jia, HJ Jiang, Y Du, F Yang… - … and cellular biology, 2013‏ - Taylor & Francis
Hepatic scavenger receptor class B type I (SR-BI) plays an important role in selective high-
density lipoprotein cholesterol (HDL-C) uptake, which is a pivotal step of reverse cholesterol …